Company Update (NYSE:LLY): China firm loses 5 years of financial documents as truck stolen

[Reuters] – China Animal Healthcare , part owned by Eli Lilly and Co, said on Wednesday it was hunting for five years-worth of financial documents that were lost after the truck carrying them was stolen as the driver took a lunch break. The documents were stolen while being transported from a storage facility in China’s northern Hebei province to the company’s headquarters in nearby Beijing. China Animal Healthcare, whose shares have been suspended since March and which is in the middle of an investigation of its accounts, said in an earlier filing on Monday the truck had been stolen on Dec. 4 in the city of Baoding. Read more on this. Eli Lilly and Company (LLY) , valued at $91.95B, started the session at $86.45. A quick look at the market, the company’s stock traded between $86.20 and $87.10 with a one year range of $68.31 to $92.85. Priced at 24.85x this year’s forecasted earnings, LLY shares are relatively expensive compared to the industry’s -2.78x forward p/e ratio. The company pays shareholders $2.04 per share in dividend income per year, for a current yield of 2.37%. Consensus earnings for the current quarter by the 18 sell-side analysts covering the stock is an estimate of $0.78 per share, which would be $0.03 better than the year-ago quarter and a $0.00 sequential decrease. Investors should also note that the full-year EPS estimate of $3.44 is a $0.66 improvement when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $5.33 Billion. If realized, that would be a 4.10% increase over the year-ago quarter. Recently, BMO Capital Markets upgraded LLY from Market Perform to Outperform (Nov 13, 2015). Previously, Credit Suisse upgraded LLY from Neutral to Outperform. The average price target for LLY shares by the analysts covering it is $99.85, which is 15.50% above where the stock opened. See more in (NYSE:LLY) Similar Articles: Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly Sets Dates and Conference Calls for 2016 Financial Guidance and Fourth-Quarter 2015 Financial Results Company Update (NYSE:LLY): Yabao Pharmaceuticals Enters Second Innovative Collaboration With Eli Lilly and Company to Develop Diabetes Treatment Company Update: Eli Lilly & Company (NYSE:LLY) – Research and Markets: Investigation Report on China’s Insulin Lispro Market, 2010-2019 Featuring Eli Lilly and Company & Gan & Lee Pharmaceuticals